412 related articles for article (PubMed ID: 32098873)
1. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
Zamanian-Daryoush M; Gogonea V; DiDonato AJ; Buffa JA; Choucair I; Levison BS; Hughes RA; Ellington AD; Huang Y; Li XS; DiDonato JA; Hazen SL
J Biol Chem; 2020 Apr; 295(15):4836-4848. PubMed ID: 32098873
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW
J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665
[TBL] [Abstract][Full Text] [Related]
4. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
5. ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesis.
Hafiane A; Genest J
Atherosclerosis; 2017 Feb; 257():90-99. PubMed ID: 28129550
[TBL] [Abstract][Full Text] [Related]
6. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
[TBL] [Abstract][Full Text] [Related]
7. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.
Shao B
Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
[TBL] [Abstract][Full Text] [Related]
9. The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles.
Nagao K; Hata M; Tanaka K; Takechi Y; Nguyen D; Dhanasekaran P; Lund-Katz S; Phillips MC; Saito H
Biochim Biophys Acta; 2014 Jan; 1841(1):80-7. PubMed ID: 24120703
[TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
11. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
[TBL] [Abstract][Full Text] [Related]
12. ATP-binding cassette transporter AI and its role in HDL formation.
Lee JY; Parks JS
Curr Opin Lipidol; 2005 Feb; 16(1):19-25. PubMed ID: 15650559
[TBL] [Abstract][Full Text] [Related]
13. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
Jin Z; Zhou L; Tian R; Lu N
Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
[TBL] [Abstract][Full Text] [Related]
15. Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis.
Hassan HH; Denis M; Lee DY; Iatan I; Nyholt D; Ruel I; Krimbou L; Genest J
J Lipid Res; 2007 Nov; 48(11):2428-42. PubMed ID: 17656736
[TBL] [Abstract][Full Text] [Related]
16. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
Thorngate FE; Yancey PG; Kellner-Weibel G; Rudel LL; Rothblat GH; Williams DL
J Lipid Res; 2003 Dec; 44(12):2331-8. PubMed ID: 12951361
[TBL] [Abstract][Full Text] [Related]
17. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte modulation of high-density lipoprotein cholesterol.
Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
[TBL] [Abstract][Full Text] [Related]
19. The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.
Chroni A; Koukos G; Duka A; Zannis VI
Biochemistry; 2007 May; 46(19):5697-708. PubMed ID: 17447731
[TBL] [Abstract][Full Text] [Related]
20. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
